FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/088988 [Registered on: 17/06/2025] Trial Registered Prospectively
Last Modified On: 17/06/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Public Health Initiative to study the role of Ayurveda in improving Hemoglobin level in women of reproductive age in Chengalpattu district of Tamilnadu 
Scientific Title of Study   A community based study to assess the role of Ayurvedic interventions and lifestyle advocacy on Iron Deficiency Anemia in women of reproductive age in Chengalpattu district of Tamilnadu 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr S Asha 
Designation  Research Officer 
Affiliation  CCRAS-Dr. Achanta Lakshmipathi Regional Ayurveda Research Institute 
Address  Room No 8, Second Floor,CCRAS-Dr. Achanta Lakshmipathi Regional Ayurveda Research Institute,VHS Hospital Campus, TTTI Post, Taramani, Chennai

Chennai
TAMIL NADU
600113
India 
Phone  9895192067  
Fax    
Email  dr.ashas2324@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr S Asha 
Designation  Research Officer 
Affiliation  CCRAS-Dr. Achanta Lakshmipathi Regional Ayurveda Research Institute 
Address  Room No 8, Second Floor,CCRAS-Dr. Achanta Lakshmipathi Regional Ayurveda Research Institute,VHS Hospital Campus, TTTI Post, Taramani, Chennai

Chennai
TAMIL NADU
600113
India 
Phone  9895192067  
Fax    
Email  dr.ashas2324@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr S Asha 
Designation  Research Officer 
Affiliation  CCRAS-Dr. Achanta Lakshmipathi Regional Ayurveda Research Institute 
Address  Room No 8, Second Floor,CCRAS-Dr. Achanta Lakshmipathi Regional Ayurveda Research Institute,VHS Hospital Campus, TTTI Post, Taramani, Chennai

Chennai
TAMIL NADU
600113
India 
Phone  9895192067  
Fax    
Email  dr.ashas2324@gmail.com  
 
Source of Monetary or Material Support  
Ayurswasthya Yojana Scheme, Ministry of Ayush, Ayush Bhawan, B Block, GPO Complex, INA, New Delhi, India PIN- 110023 
 
Primary Sponsor  
Name  Ministry of Ayush 
Address  Ayush Bhawan, B Block, GPO Complex, INA, New Delhi- 110023 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr S Asha  CCRAS-Dr. Achanta Lakshmipathi Regional Ayurveda Research Institute, Chennai  Room No 8, 2nd Floor, CCRAS-Dr. Achanta Lakshmipathi Regional Ayurveda Research Institute, VHS Hospital Campus, TTTI Post, Taramani,Chennai
Chennai
TAMIL NADU 
9895192067

dr.ashas2324@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee of CCRAS-Dr. Achanta Lakshmipathi Regional Ayurveda Research Institute,Chennai  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D509||Iron deficiency anemia, unspecified. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmLifestyle--Dinacarya: Nil, Ritucarya: Nil, Acara Rasayana:Nil, Other:Nil, Pathya/Apathya:yes, Pathya:Ayurveda Based dietary practices. Diet for improving Hemoglobin level in reproductive age women. including beet root, green leafy vegetables, til, red rice, red meat, egg, cashew, sardine, green peas etc., Apathya:Diet hindering with iron absorption in body like mustard leaves, maida, urad dal, excess of dairy products, taking tea/coffee immediately after diet, fried and baked foods etc.
2Intervention ArmDrugClassical(1) Medicine Name: Punarnavadi Mandura, Reference: Caraka Samhita, Chikitsa Sthana, Chapter16, Sloka 93-95, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: water), Additional Information: NIL
(2) Medicine Name: Dadimadi Ghrita, Reference: Ashtanga Hrudayam, Chikitsa Sthana, Chapter 16, Sloka 2-4, Route: Oral, Dosage Form: Ghrita, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: water), Additional Information: NIL
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  49.00 Year(s)
Gender  Female 
Details  Non-pregnant non-lactating women of reproductive age(15 to 49years),Hb greater than or equal to 8 gm percentage and less than 12 gm percentage,intend to remain in the study site for the next 6 months atleast, willingness to sign the informed consent form(Written assent in participants below 18 years of age) and to participate in the study related activities such as adherence to lifestyle advocacy,study intervention, logging in compliance log, etc.
 
 
ExclusionCriteria 
Details  Severe anemia(less than 8gm percentage) warranting immediate referral and care, history of diagnosis of other types of anemia, Women with menstrual irregularities such as menorrhagia, irregular menstrual cycles, cycle duration less than 24 days, History of any chronic or other medical condition (e.g. IBS, IBD, malignancy) requiring frequent medical attention or potentially interfering with nutritional status, malnutrition warranting medical attention, Obesity (BMI greater than or equal to 29.9),any chronic or acute illness that require intake of any other medications other than oral hypoglycemic agents or anti-hypertensive, any other condition that, as per the PI would adversely affect participation in the study or the outcome of the study.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Change in Hemoglobin level   To be assessed during baseline,90thday and 180th Day  
 
Secondary Outcome  
Outcome  TimePoints 
1.Change in the other blood indices such as RBC Count, MCV, MCHC, and PCV
2.Change in Serum Ferritin level
3.Medication adherence and compliance to lifestyle advocacy
4.Documentation of demographic characteristics and severity of anemia through pre-designed questionnaire to assess the association between both
 
1. To be assessed during baseline,90thday and 180th Day
2. To be assessed during baseline,90thday and 180th Day
3. To be assessed during 30th, 60th and 90th day
4.To be assessed during Baseline 
 
Target Sample Size   Total Sample Size="1120"
Sample Size from India="1120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   07/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The present study is conducted to assess the role of Ayurvedic Interventions and Lifestyle advocacy on Iron Deficiency anemia in women of reproductive age in a selected district in Tamil Nadu. It is a single arm study in which willing reproductive-age women (15 to 49 years age) will be enrolled. It will be carried out in 1120 participants and the total duration of study will be 3 years. Ayurvedic Medicines viz, Punarnavadi Mandura and Dadimadi Ghritha and lifestyle advocacy will be adviced to follow for 90 days. The primary outcome will be change in Hemoglobin level which will be assessed during baseline, 90th day and 180th day.  Secondary outcomes include change in blood indices such as RBC Count, MCV, MCHC, and PCV, Change in Serum ferritin, Medication adherence and compliance to lifestyle advocacy and documentation of demographic characteristics and severity of anemia through pre-designed questionnaire to assess the association between both. 
Close